Navigation Links
BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries
Date:6/6/2013

Bloomington, Indiana (PRWEB) June 06, 2013

BioConvergence, a contract service provider for pharmaceutical and biotechnology companies, recently launched a life sciences blog that addresses industry best practices.

The blog will cover a wide range of topics including testing and development, quality assurance, production, and supply chain management and security. The breadth of topics is well-suited to the organization, according to Lesli Stasiek, Global Manager of Business Development and Marketing:

“As a contract service provider, we produce unique solutions for life sciences organizations, regardless of their size or product development stage. Beyond this, our team members have gathered to BioConvergence from a wide variety of industry firms of different sizes, and many have worked with contract firms as clients themselves. These factors have given our team a broad perspective of the best practices realm that I know our readership will find both interesting and relevant.”

In addition to the articles supplied by BioConvergence, the company’s alliance partner Modality Solutions will also be contributing regularly.

Modality Solutions employs a Transport Simulation Laboratory of their design to simulate the rigors that pharmaceutical products are exposed to during transportation. BioConvergence then offers the support testing, quality assurance, and storage services needed to accommodate recommendations for formulation improvement.

Modality’s principals add over 100 years of combined life sciences experience to the nearly 500 years represented by the BioConvergence team. BioConvergence hopes that industry professionals, regardless of role, will “take advantage of this resource and gain greater visibility to industry trends and knowledge,” according to Stasiek.

To access BioConvergence’s corporate blog and additional resources, please visit http://blog.bioc.us.

About BioConvergence

BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain management. A women-owned and operated business headquartered in Bloomington, Indiana, BioConvergence has a team of over 50 members with nearly five centuries’ worth of combined experience in the life sciences industry. The company’s unique E-Transparency® System provides transparency and flexibility to its clients, along with superior, quality-driven outsourcing solutions. For more information, visit http://www.BioC.us.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10807732.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
2. BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
3. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
4. MAX Launches "Double HELIX" in Marylands Biotechnology Corridor
5. Salimetrics Launches a Faster, More Accurate, Salivary Melatonin Assay
6. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
7. Puritan Medical Products Launches New Series to Tell Customer Stories
8. Dr. Althauser Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
9. Brookfield Dental Care Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Elsevier Launches New Open Access Journal: Translational Proteomics
11. Project Oncology CME Series Launches on ReachMD, Offering Learners a Wide Array of Certified Oncology Activities Across an Integrated Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.24 per share will ... of record as of the close of business on June ... of the Board of Directors and may be adjusted as ...
(Date:5/23/2016)... LONDON , May 23, 2016 ... Efficiency by 40% - Frontage Implement a Single Platform ... Quality, Compliance and Traceability Within the Bioanalytical lab Frontage ... the United States and China ... across its laboratory facilities. In addition to serving as the global ...
(Date:5/23/2016)... ... 23, 2016 , ... Foresight Institute , a leading ... for the 2015 Foresight Institute Feynman Prizes. , These prestigious prizes, named ... for experiment and the other for theory in nanotechnology. Prof. Markus J. Buehler, ...
(Date:5/20/2016)... ... May 20, 2016 , ... The leading Regenerative Veterinary Medicine Company, VetStem ... have treated over 100 of their own patients with the VetStem Cell Therapy. Each ... of care for their patients. , The veterinarians are Dr Ross Rich former ...
Breaking Biology Technology:
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):